NM_033395.2:c.7668G>T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_033395.2(CEP295):​c.7668G>T​(p.Arg2556Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000215 in 1,394,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000022 ( 0 hom. )

Consequence

CEP295
NM_033395.2 missense, splice_region

Scores

3
15
Splicing: ADA: 0.8701
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0260

Publications

0 publications found
Variant links:
Genes affected
CEP295 (HGNC:29366): (centrosomal protein 295) Enables microtubule binding activity. Involved in several processes, including centriole replication; positive regulation of protein acetylation; and regulation of centrosome duplication. Located in cytosol; microtubule cytoskeleton; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
TAF1D (HGNC:28759): (TATA-box binding protein associated factor, RNA polymerase I subunit D) TAF1D is a member of the SL1 complex, which includes TBP (MIM 600075) and TAF1A (MIM 604903), TAF1B (MIM 604904), and TAF1C (MIM 604905), and plays a role in RNA polymerase I transcription (Wang et al., 2004 [PubMed 15520167]; Gorski et al., 2007 [PubMed 17318177]).[supplied by OMIM, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16086787).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP295NM_033395.2 linkc.7668G>T p.Arg2556Ser missense_variant, splice_region_variant Exon 29 of 30 ENST00000325212.11 NP_203753.1 Q9C0D2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP295ENST00000325212.11 linkc.7668G>T p.Arg2556Ser missense_variant, splice_region_variant Exon 29 of 30 2 NM_033395.2 ENSP00000316681.6 Q9C0D2-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000652
AC:
1
AN:
153288
AF XY:
0.0000123
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000233
GnomAD4 exome
AF:
0.00000215
AC:
3
AN:
1394598
Hom.:
0
Cov.:
33
AF XY:
0.00000291
AC XY:
2
AN XY:
687980
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31226
American (AMR)
AF:
0.00
AC:
0
AN:
35102
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25048
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49138
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5656
European-Non Finnish (NFE)
AF:
0.00000186
AC:
2
AN:
1076382
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000251
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 03, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.7668G>T (p.R2556S) alteration is located in exon 29 (coding exon 28) of the CEP295 gene. This alteration results from a G to T substitution at nucleotide position 7668, causing the arginine (R) at amino acid position 2556 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
17
DANN
Benign
0.92
DEOGEN2
Benign
0.024
T;.;T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.80
T;T;T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.16
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
0.026
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.8
N;D;D
REVEL
Benign
0.23
Sift
Uncertain
0.012
D;D;D
Sift4G
Uncertain
0.013
D;D;D
Polyphen
0.83
P;P;.
Vest4
0.54
MutPred
0.20
Loss of MoRF binding (P = 0.0286);.;.;
MVP
0.014
MPC
0.10
ClinPred
0.42
T
GERP RS
-5.2
Varity_R
0.14
gMVP
0.19
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.87
dbscSNV1_RF
Benign
0.47
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1381155285; hg19: chr11-93463215; API